Background: Patients with steroid-resistant nephrotic syndrome (SRNS) tend to progress to end-stage renal disease (ESRD). Although the risk of steroid resistance depends mainly on histopathology, other factors, such as cytokines, may contribute to this condition. Cytokine macrophage Migration Inhibitory Factor (MIF) acts to counterregulate glucocorticoids, which have become the main drug therapy for NS. The aim of this study was to evaluate whether raised serum MIF levels represent a potential risk factor for SRNS patients.
Introduction
Idiopathic Nephrotic Syndrome (NS) represents a heterogeneous group of glomerular disorders occurring mainly in children. Generally, NS is divided into steroid sensitive (SSNS) and Steroid Resistant Nephrotic Syndrome (SRNS), depending on the response to steroid therapy. SRNS accounts for more than 10% of children who progress to chronic kidney disease [1] . This grip of NS has in common permanent loss of selectivity of the glomerular barrier to protein filtration. It has been recognized that patients with persistent high grade proteinuria are more likely to develop chronic kidney disease than patients with low grade or no proteinuria [2] .
The risk of steroid resistance among NS children is affected by many factors. While the risk of steroid resistance depends mainly on histopathology, other factors, such as cytokines, may contribute to this condition. The production of MIT cytokine represents a physiologic counter regulator to the anti-inflammatory and immunosuppressive effects of glucocorticoids [3] . This cytokine is induced by glucocorticoids, and then acts to counter-regulate the inflammatory action of glucocorticoids [4] . Higher MIF levels can inhibit the action glucocorticoids The role of higher serum MIF levels and their correlation with level of plasma angiotensin II have not yet been elucidated especially as risk factor for steroid resistance in NS. One study reported elevated serum MIF concentrations in chronic kidney disease patients [9] . However, that study focused on adults with a wide range of glomerular filtration rates. Furthermore, since most mechanical aspects of serum MIF action have not yet been fully elucidated, the current study sought to determine whether higher serum MIF levels are a potential risk factor for SRNS patients.
